Evidence map›Paper›PMID 29896197›Full record

ArticleFrontiers in immunology2018

Vaccination With Recombinant Filamentous

João F Gomes-Neto, Rossella Sartorius, Fábio B Canto, Thamyres S Almeida, André A Dias, Carlos-Henrique D Barbosa, Guilherme A Melo, Ana Carolina Oliveira, Pedro-Henrique N Aguiar, Carlos R Machado and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Cytotoxic CD4eLife · 2022
    Article
  7. Article
  8. Review
  9. Advancements in protein nanoparticle vaccine platforms to combat infectious disease.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2021
    Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

João F Gomes-NetoInstituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Rossella SartoriusInstitute of Protein Biochemistry, CNR, Naples, Italy.
Fábio B CantoInstituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Thamyres S AlmeidaInstituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
André A DiasInstituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Carlos-Henrique D BarbosaInstituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Guilherme A MeloInstituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Ana Carolina OliveiraInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Pedro-Henrique N AguiarInstituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Carlos R MachadoInstituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Herbert L de Matos GuedesInstituto de Biofísica Carlos Chagas Filho, Polo Xerém, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Marcelo F SantiagoInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Alberto NóbregaInstituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Piergiuseppe De BerardinisInstitute of Protein Biochemistry, CNR, Naples, Italy.
Maria BellioInstituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Universidade Federal do Rio de Janeiro · BRInstitute of Protein Biochemistry · ITUniversidade Federal de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recombinant filamentous

Indexed as

Bacteriophage M13Chagas DiseaseGene Expression RegulationProtozoan VaccinesToll-Like Receptor 9Trypanosoma cruziVaccinationAnimalsMiceMice, KnockoutProtozoan VaccinesTlr9 protein, mouseToll-Like Receptor 9CD8 T cellscytotoxic T celldelivery systemfd phagesTlr9Trypanosoma cruzivaccine

Identifiers

PMID29896197
PMCPMC5987186
OpenAlexW2801997013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.